Compared with those in the BT group , patients in the dMT group were less likely to experience symptomatic intracranial hemorrhage ( OR , 0.68 ; 0.95 CI , 0.51 - 0.91 ; P = 0.008 ) or any intracranial hemorrhage ( OR , 0.71 ; 0.95 CI , 0.61 - 0.84 ; P < 0.001 ) .